{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:15:38Z","timestamp":1792034138981,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpba.2026.117671","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:56:26Z","timestamp":1784789786000},"page":"117671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrating Box\u2013Behnken and Plackett\u2013Burman designs for the robust impurity profiling of levodopa and carbidopa tablets"],"prefix":"10.1016","volume":"281","author":[{"given":"Daria Angelika","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Gen\u00e7er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Arabac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117671_bib1","unstructured":"U.S.P. Convention, United States Pharmacopeia and National Formulary (USP 47\u2013NF 42), (2024)."},{"key":"10.1016\/j.jpba.2026.117671_bib2","unstructured":"European Directorate for the Quality of Medicines, European Pharmacopoeia, 11.8, 2024."},{"key":"10.1016\/j.jpba.2026.117671_bib3","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Q2(R2) Guideline on validation of analytical procedures, 2024."},{"key":"10.1016\/j.jpba.2026.117671_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1208\/s12248-022-00685-2","article-title":"Analytical Quality by Design, Life Cycle Management, and Method Control","volume":"24","author":"Verch","year":"2022","journal-title":"AAPS J."},{"issue":"R1","key":"10.1016\/j.jpba.2026.117671_bib5","article-title":"International Conference on Harmonization of Technical Requirements for registration of pharmaceuticals for human use","volume":"9","author":"ICH","year":"2023","journal-title":"Harmon. Guidel. Qual. Risk Manag. Q"},{"key":"10.1016\/j.jpba.2026.117671_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113507","article-title":"Development of a green HPLC method for the analysis of artesunate and amodiaquine impurities using Quality by Design","volume":"190","author":"Yabr\u00e9","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112943","article-title":"Optimization of a liquid chromatography method for the analysis of related substances in daclatasvir tablets using design of experiments integrated with the steepest ascent method and Monte Carlo simulation","volume":"178","author":"Tol","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfueco.2023.100091","article-title":"Box Behnken design application for optimization of bio-oil yield from catalytic pyrolysis of agro-residue","volume":"16","author":"Oyebanji","year":"2023","journal-title":"Fuel Commun."},{"key":"10.1016\/j.jpba.2026.117671_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/bio.2618","article-title":"Simultaneous estimation of levodopa and carbidopa by RP-HPLC using a fluorescence detector: its application to a pharmaceutical dosage form","volume":"29","author":"Raut","year":"2014","journal-title":"Luminescence"},{"key":"10.1016\/j.jpba.2026.117671_bib11","first-page":"530","article-title":"A simple high-performance liquid chromatography method development for Carbidopa and Levodopa impurities: evaluation of risk assessment before method validation by Quality by Design approach","volume":"3","author":"Subramanian","year":"2020","journal-title":"Sep. Sci."},{"key":"10.1016\/j.jpba.2026.117671_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10826076.2012.758138","article-title":"Stability-Indicating HPLC Method For Simultaneous Determination Of Captopril, Indapamide, And Their Related Compounds","volume":"37","author":"El-Gindy","year":"2014","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2026.117671_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114306","article-title":"Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles","volume":"205","author":"Abreu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113729","article-title":"Ultra high-performance liquid chromatography method development for separation of formoterol, budesonide, and related substances using an analytical quality by design approach","volume":"193","author":"Alkhateeb","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib15","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Harmonised Guideline Q14: Analytical Procedure Development, 2023."},{"key":"10.1016\/j.jpba.2026.117671_bib16","doi-asserted-by":"crossref","first-page":"40346","DOI":"10.1021\/acsomega.4c01183","article-title":"A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach","volume":"9","author":"Arabaci","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117671_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4274\/tjps.galenos.2020.89725","article-title":"Development and Validation of an HPLC Method Using an Experimental Design for Analysis of Amlodipine Besylate and Enalapril Maleate in a Fixed-dose Combination","volume":"18","author":"SARISALTIK YASIN","year":"2021","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117671_bib18","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1007\/s11696-021-01532-y","article-title":"A simple and efficient method for simultaneous quantification of levodopa and carbidopa based on controlled oxidation process","volume":"75","author":"Andrade","year":"2021","journal-title":"Chem. Pap."},{"key":"10.1016\/j.jpba.2026.117671_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15671\/hjbc.795609","article-title":"Development and Validation of a Effective and Reliable HPLC Method for the Quantification of Levodopa and Carbidopa in Pharmaceutical Formulations","volume":"49","author":"Bulduk","year":"2021","journal-title":"Hacet. J. Biol. Chem."},{"key":"10.1016\/j.jpba.2026.117671_bib20","unstructured":"International Conference on Harmonisation, ICH Harmonised Guideline Q3B(R2): Impurities in New Drug Products, (2006)."},{"key":"10.1016\/j.jpba.2026.117671_bib21","doi-asserted-by":"crossref","unstructured":"United States Pharmacopeia, Carbidopa and Levodopa Tablets, USP Monograph: Levodopa and Carbidopa Tablets, 2024. https:\/\/doi.org\/10.31003\/USPNF_M12870_09_01.","DOI":"10.31003\/USPNF_M12870_09_01"},{"key":"10.1016\/j.jpba.2026.117671_bib22","article-title":"Quality by Design Tool Assessed Ultraperformance Liquid Chromatography Method for the Analysis of Remogliflozin and Teneligliptin in Oral Dosage Form","author":"Menda","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117671_bib23","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1021\/acsomega.2c06038","article-title":"Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies","volume":"8","author":"Azhakesan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117671_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114231","article-title":"QBD-driven HPLC method of eltrombopag olamine: Degradation pathway proposal, structure elucidation, and in silico toxicity prediction","volume":"203","author":"Jayagopal","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib25","first-page":"337","article-title":"Robust In Vitro HPLC-DAD Method for Accurate Quantification of N-Carbamylglutamate in Drug Formulations","volume":"44","author":"Arabaci","year":"2024","journal-title":"Hacet. Univ. J. Fac. Pharm."},{"key":"10.1016\/j.jpba.2026.117671_bib26","doi-asserted-by":"crossref","unstructured":"U.S.P. Convention, \u30081220\u3009 Analytical Procedure Life Cycle, 2024. https:\/\/doi.org\/10.31003\/USPNF_M10975_02_01.","DOI":"10.31003\/USPNF_M10975_02_01"},{"key":"10.1016\/j.jpba.2026.117671_bib27","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Technical And Regulatory Considerations For Pharmaceutical Product Lifecycle Management, (2020)."},{"key":"10.1016\/j.jpba.2026.117671_bib28","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Analytical Procedure Development Q14, (2022)."},{"key":"10.1016\/j.jpba.2026.117671_bib29","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1021\/acsomega.5c07999","article-title":"Box\u2013Behnken Design-Based Optimized UHPLC Method for the Analysis of Lipid-Based SNEDDS Ferrying Hydrocortisone and Thymoquinone","volume":"11","author":"Altamimi","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117671_bib30","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.5c09012","article-title":"A Novel Sol\u2013Gel Synthesis Strategy of Co-Based Sillenite Composites for Enhanced Electrocatalysis of Water Splitting","author":"Acioli","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117671_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2024.105243","article-title":"Recent applications of analytical quality-by-design methodology for chromatographic analysis: A review","volume":"254","author":"Xuan","year":"2024","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.jpba.2026.117671_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpha.2013.09.003","article-title":"Development of forced degradation and stability indicating studies of drugs\u2014A review","volume":"4","author":"Blessy","year":"2014","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2026.117671_bib33","doi-asserted-by":"crossref","DOI":"10.33483\/jfpau.1238180","article-title":"Application of Plackett-Burman Design For development and evaluation of a betamethasone suspension for injection formulation","author":"Yerlikaya","year":"2023","journal-title":"Ank. Univ. Eczaci Fak. Derg."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:46:36Z","timestamp":1790113596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0731708526003390"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117671","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Box\u2013Behnken and Plackett\u2013Burman designs for the robust impurity profiling of levodopa and carbidopa tablets","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117671"}}